WALMART INC (WMT)       143.3  +1.09 (+0.77%)

143.3  +1.09 (+0.77%)

US9311421039 - Common Stock - After market: 143.25 -0.05 (-0.03%)


Fundamental Rating

3

Overall WMT gets a fundamental rating of 3 out of 10. We evaluated WMT against 43 industry peers in the Food & Staples Retailing industry. The financial health of WMT is medium. Also its profitability is quite bad. WMT is valued expensive and it does not seem to be growing.




Profitability

Profitability Rating

2

WMT has a good Piotroski-F score of 7.00. This indicates a good health and good profitability for WMT.
WMT has a Return On Assets of 3.62%. This is below the industry average of 4.35%.

WMT has a Return On Equity of 12.41%. This is below the industry average of 13.71%.
WMT has a Profit Margin of 1.49%. This is below the industry average of 2.47%.
VS Industry

ROA (3.62%) VS Industry: 36% outperformed.

0.56
11.88

ROE (12.41%) VS Industry: 30% outperformed.

1.00
129.68

Profit Margin (1.49%) VS Industry: 26% outperformed.

0.37
5.35

Valuation

Valuation Rating

0

With a Price/Earnings Ratio of 23.49, WMT is valued on the expensive side.
With a Forward Price/Earnings Ratio of 21.68, WMT is valued rather expensively.
With a price book ratio of 5.35, WMT is valued correctly.
With a Price/Earning Ratio of 23.49, WMT is valued a higher than the industry average, which is at 18.20. 88% of the companies listed in the same industry are cheaper than WMT!

The high PEG Ratio, which compensates the Price/Earnings for growth, indicates WMT does not grow enough to justify the current Price/Earnings ratio.
When comparing the price book ratio of WMT to the average industry price book ratio of 2.34, WMT is valued more expensive than its industry peers. 85% of the companies listed in the same industry are valued cheaper.
Compared to an average industry Enterprise Value to EBITDA ratio of 9.04, WMT is valued more expensive than its industry peers.
VS Industry

Price/Earnings (23.49) VS Industry: 12% outperformed.

47.24
2.27

Price/Book (5.35) VS Industry: 15% outperformed.

35.39
0.22

Enterprise Value/ EBITDA (13.07) VS Industry: 21% outperformed.

22.45
2.83

Growth

Growth Rating

3

The earnings per share for WMT have decreased by -4.39% in the last year.
Measured over the past 5 years, WMT shows a small growth in Earnings Per Share. The EPS has been growing by 8.30% on average per year.
The Earnings Per Share is expected to grow by 5.52% on average over the next 5 years.
The Revenue has been growing slightly by 4.92% in the past year.

WMT shows a small growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 3.34% yearly.
Based on estimates for the next 5 years, WMT will show a small growth in Revenue. The Revenue will grow by 3.63% on average per year.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is stable.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS8.3% 9.45% -4.39% -4.95% 1.23% 4% 5.52%
Revenue3.34% 3.65% 4.92% 6.05% 4.4% 4.06% 3.63%

Health

Health Rating

4

WMT has an Altman-Z score of 4.40. This indicates that WMT is financially healthy and little risk of bankruptcy at the moment.
The Altman-Z score of WMT is much better than the industry average of 3.16.
WMT has a good Piotroski-F score of 7.00. This indicates a good health and good profitability for WMT.
The Debt to Equity ratio of WMT is in line with the industry averages.

WMT has a Current Ratio of 0.86. This is a bad value and indicates that WMT is not financially healthy enough and could expect problems in meeting its short term obligations.
When comparing the Current Ratio of WMT to the average industry Current Ratio of 1.34, WMT is less able to pay its short term obligations than its industry peers. 88% of its industry peers have a better Current Ratio.
A Quick Ratio of 0.23 indicates that WMT may have some problems paying its short term obligations.
When comparing the Quick Ratio of WMT to the average industry Current Ratio of 0.71, WMT is less able to pay its short term obligations than its industry peers. 95% of its industry peers have a better Quick Ratio.
VS Industry

Debt/Equity (0.53) VS Industry: 57% outperformed.

9.20
0.00

Quick Ratio (0.23) VS Industry: 5% outperformed.

0.14
41.55

Current Ratio (0.86) VS Industry: 12% outperformed.

0.70
41.75

Altman-Z (4.4) VS Industry: 72% outperformed.

-6.80
7.27

Dividend

Dividend Rating

4

WMT has paid a dividend for at least 10 years, which is a reliable track record.
WMT has a Yearly Dividend Yield of 1.59%.
WMT's Dividend Yield is comparable with the industry average which is at 1.81.
The dividend of WMT has a limited annual growth rate of 1.89%.

Compared to the average S&P500 Dividend Yield of 2.41, WMT is paying slightly less dividend.
WMT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
WMT pays out 68.31% of its income as dividend. This is not a sustainable payout ratio.
VS Industry

Dividend Yield (1.59%) VS Industry: 45% outperformed.

0.59
5.35

WALMART INC143.3

NYSE:WMT (1/27/2023, 7:04:00 PM)+1.09 (+0.77%)

After market: 143.25 -0.05 (-0.03%)

Chartmill FA Rating
GICS Sector Consumer Staples
GICS IndustryGroup Food & Staples Retailing
GICS Industry Food & Staples Retailing
Earnings (Last) 11-15 2022-11-15/bmo Earnings (Next) 02-21 2023-02-21
Inst Owners 32.38% Inst Owner Change 0.06%
Ins Owners 0.9% Ins Owner Change -0.68%
Market Cap 386.45B Analysts 80
Price Target 164.35 (14.69%)

Dividend
Dividend Yield 1.59% Dividend Growth 1.89%
DP 68.31% Ex-Date N/A

Surprises & Revisions
EPS beat(2) 2 Avg EPS beat(2) 10.3%
Min EPS beat(2) 8.08% Max EPS beat(2) 12.52%
EPS beat(4) 3 Avg EPS beat(4) 2.14%
Min EPS beat(4) -13.15% Max EPS beat(4) 12.52%
Revenue beat(2) 2 Avg Revenue beat(2) 1.38%
Min Revenue beat(2) 0.36% Max Revenue beat(2) 2.41%
Revenue beat(4) 3 Avg Revenue beat(4) 0.88%
Min Revenue beat(4) -0.12% Max Revenue beat(4) 2.41%
PT rev (1m) -0.03% EPS NQ rev (1m) 2.94%
EPS NY rev (1m) 0% Revenue NQ rev (1m) 0.34%
Revenue NY rev (1m) 0%

Valuation
Industry RankSector Rank
PE 23.49
Fwd PE 21.68
P/S 0.64
P/FCF 55.14
P/OCF 16.38
P/B 5.35
P/tB 8.76
EV/EBITDA 13.07
EPS(TTM) 6.1 EY 4.26%
EPS(NY) 6.61 Fwd EY 4.61%
FCF(TTM) 2.6 FCFY 1.81%
OCF(TTM) 8.75 OCFY 6.1%
SpS 222.53 BVpS 26.79
TBVpS 16.36 PEG (NY) N/A
PEG (5Y) 2.83

Profitability
Industry RankSector Rank
ROA 3.62%
ROE 12.41%
ROIC 9.8%
ROICexc 10.61%
ROICexgc 13.24%
OM 3.54%
PM 1.49%
GM 24.38%
ROICexgc(3y) 15.54% ROICexcg growth 3Y 7.07%
ROICexcg growth 5Y 3.67% ROICexc(3y) 12.36%
ROICexc growth 3Y 8.03% ROICexc growth 5Y 1.99%
OM growth 3Y 5.17% OM growth 5Y 1.17%
PM growth 3Y 22.56% PM growth 5Y -3.19%
GM growth 3Y 0% GM growth 5Y -0.43%
F-Score 7 Asset Turnover 2.42

Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 7.31
Debt/EBITDA 1.6
Cap/Depr 152.94%
Profit Quality 78.16%
Current Ratio 0.86
Quick Ratio 0.23
Altman-Z 4.4
F-Score 7 WACC 7.63%
ROIC/WACC 1.73 Cap/Depr(3y) 104.15%
Cap/Depr(5y) 100.95% Profit Quality(3y) 127.78%
Profit Quality(5y) 165.95%

Growth
EPS 1Y -4.39% EPS 3Y 9.45%
EPS 5Y 8.3% EPS growth Q2Q 3.45%
EPS Next Y -4.95% EPS Next 2Y 1.23%
EPS Next 3Y 4% EPS Next 5Y 5.52%
Revenue growth 1Y 4.92% Revenue growth 3Y 3.65%
Revenue growth 5Y 3.34% Revenue growth Q2Q 8.74%
Revenue Next Year 6.05% Revenue Next 2Y 4.4%
Revenue Next 3Y 4.06% Revenue Next 5Y 3.63%
EBIT growth 1Y -25.27% EBIT growth 3Y 9.01%
EBIT growth 5Y 4.55% EBIT Next Year 34.09%
EBIT Next 3Y 14.81% EBIT Next 5Y 10.89%
FCF growth 1Y -71.06% FCF growth 3Y -9.46%
FCF growth 5Y -9.3% OCF growth 1Y -29.79%
OCF growth 3Y -2.12% OCF growth 5Y -3.85%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA